{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:56:36Z","timestamp":1768427796971,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T00:00:00Z","timestamp":1530921600000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["314730-166609"],"award-info":[{"award-number":["314730-166609"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009691","name":"Nuovo-Soldati foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FLAGS Foundation"},{"name":"Roche Pharma (Schweiz) AG"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cld.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T14:30:21Z","timestamp":1492785021000},"page":"465-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cardiovascular Manifestations of Hepatitis C Virus"],"prefix":"10.1016","volume":"21","author":[{"given":"Nicolas","family":"Goossens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2017.03.003_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2017.03.003_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.cld.2017.03.003_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2017.03.003_bib4","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/hep.26905","article-title":"Is genotype 3 of the hepatitis C virus the new villain?","volume":"59","author":"Goossens","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2017.03.003_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/1574887109666141216101939","article-title":"Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection","volume":"9","author":"Goossens","year":"2014","journal-title":"Rev Recent Clin Trials"},{"issue":"11","key":"10.1016\/j.cld.2017.03.003_bib6","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1111\/j.1572-0241.2002.07056.x","article-title":"Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a","volume":"97","author":"Hofer","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2017.03.003_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/aje\/kwm370","article-title":"Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors","volume":"167","author":"Guiltinan","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cld.2017.03.003_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.drugalcdep.2015.03.026","article-title":"The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: an Australian population-based cohort study","volume":"152","author":"Vajdic","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.cld.2017.03.003_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2015.09.007","article-title":"Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies","volume":"150","author":"Petta","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2017.03.003_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2893.2012.01633.x","article-title":"Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?","volume":"19","author":"Fabrizi","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"issue":"1","key":"10.1016\/j.cld.2017.03.003_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1253\/circj.67.26","article-title":"Association between hepatitis C virus core protein and carotid atherosclerosis","volume":"67","author":"Ishizaka","year":"2003","journal-title":"Circ J"},{"issue":"9301","key":"10.1016\/j.cld.2017.03.003_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(02)07339-7","article-title":"Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening","volume":"359","author":"Ishizaka","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cld.2017.03.003_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0021-9150(02)00388-X","article-title":"Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity","volume":"166","author":"Tomiyama","year":"2003","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.cld.2017.03.003_bib14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.289.10.1245-a","article-title":"Hepatitis C virus and atherosclerosis in patients with type 2 diabetes","volume":"289","author":"Fukui","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cld.2017.03.003_bib15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.25508","article-title":"Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations","volume":"55","author":"Petta","year":"2012","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2017.03.003_bib16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gut.2009.202317","article-title":"Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors","volume":"59","author":"Mostafa","year":"2010","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2017.03.003_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jhep.2014.09.022","article-title":"Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based cohort study","volume":"62","author":"Hsu","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"13","key":"10.1016\/j.cld.2017.03.003_bib18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0b013e32832d7aa8","article-title":"Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women\u2019s interagency HIV study","volume":"23","author":"Tien","year":"2009","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.cld.2017.03.003_bib19","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/STROKEAHA.110.598136","article-title":"Hepatitis C virus infection and increased risk of cerebrovascular disease","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.cld.2017.03.003_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/apt.12234","article-title":"Associations of chronic hepatitis C with metabolic and cardiac outcomes","volume":"37","author":"Younossi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"46","key":"10.1016\/j.cld.2017.03.003_bib21","doi-asserted-by":"crossref","first-page":"e2132","DOI":"10.1097\/MD.0000000000002132","article-title":"Increased risk of intracerebral hemorrhage among patients with hepatitis C virus infection","volume":"94","author":"Tseng","year":"2015","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.cld.2017.03.003_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/hrt.2003.018937","article-title":"Evidence for association between hepatitis C virus seropositivity and coronary artery disease","volume":"90","author":"Vassalle","year":"2004","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.cld.2017.03.003_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/599371","article-title":"Hepatitis C virus infection and the risk of coronary disease","volume":"49","author":"Butt","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.cld.2017.03.003_bib24","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.amjcard.2014.09.020","article-title":"Impact of hepatitis C seropositivity on the risk of coronary heart disease events","volume":"114","author":"Pothineni","year":"2014","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.cld.2017.03.003_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/jiv396","article-title":"A\u00a0cross-sectional study of the association between chronic hepatitis C virus infection and subclinical coronary atherosclerosis among participants in the multicenter AIDS cohort study","volume":"213","author":"McKibben","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.cld.2017.03.003_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jvh.12447","article-title":"Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients","volume":"23","author":"Fern\u00e1ndez-Montero","year":"2016","journal-title":"J\u00a0Viral Hepat"},{"issue":"4","key":"10.1016\/j.cld.2017.03.003_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2893.2011.01545.x","article-title":"Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study","volume":"19","author":"Forde","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2017.03.003_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.puhe.2016.04.005","article-title":"Hepatitis C and risk of coronary atherosclerosis\u2013A systematic review","volume":"138","author":"Olubamwo","year":"2016","journal-title":"Public Health"},{"issue":"2","key":"10.1016\/j.cld.2017.03.003_bib29","first-page":"149","article-title":"Current level of evidence on causal association between Hepatitis C virus and type 2 diabetes: a review","volume":"8","author":"Gastaldi","year":"2017","journal-title":"J\u00a0Adv Res"},{"issue":"5","key":"10.1016\/j.cld.2017.03.003_bib30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J\u00a0Hepatol"},{"issue":"14","key":"10.1016\/j.cld.2017.03.003_bib31","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3748\/wjg.v18.i14.1642","article-title":"Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis","volume":"18","author":"Naing","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2017.03.003_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2017.03.003_bib33","doi-asserted-by":"crossref","first-page":"e0157098","DOI":"10.1371\/journal.pone.0157098","article-title":"Drug pricing evolution in hepatitis C","volume":"11","author":"Vernaz","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cld.2017.03.003_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/apt.12391","article-title":"Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan","volume":"38","author":"Hsu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2017.03.003_bib35","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2017.03.003_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.27766","article-title":"Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes","volume":"62","author":"Innes","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2017.03.003_bib37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.gastro.2016.09.009","article-title":"Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications","volume":"152","author":"Nahon","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2017.03.003_bib38","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jhep.2014.05.032","article-title":"Chronic HCV infection increases cardiac left ventricular mass index in normotensive patients","volume":"61","author":"Perticone","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2017.03.003_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cardfail.2008.12.003","article-title":"Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study","volume":"15","author":"Tsui","year":"2009","journal-title":"J\u00a0Card Fail"},{"issue":"Pt 12","key":"10.1016\/j.cld.2017.03.003_bib40","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1099\/vir.0.81056-0","article-title":"Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells","volume":"86","author":"Balasubramanian","year":"2005","journal-title":"J\u00a0Gen Virol"},{"issue":"22385985","key":"10.1016\/j.cld.2017.03.003_bib41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis","volume":"221","author":"Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cld.2017.03.003_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2012.07.045","article-title":"Myocardial injury in patients with chronic hepatitis C infection","volume":"58","author":"Maruyama","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2017.03.003_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2009.10.005","article-title":"Hepatitis C virus RNA localization in human carotid plaques","volume":"47","author":"Boddi","year":"2010","journal-title":"J\u00a0Clin Virol"},{"issue":"17335930","key":"10.1016\/j.cld.2017.03.003_bib44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2007.01.021","article-title":"Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C","volume":"46","author":"Targher","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2017.03.003_bib45","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1253\/circj.CJ-08-0459","article-title":"Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system","volume":"72","author":"Alyan","year":"2008","journal-title":"Circ J"},{"issue":"1S","key":"10.1016\/j.cld.2017.03.003_bib46","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jhep.2014.08.003","article-title":"Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases","volume":"61","author":"Negro","year":"2014","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611730020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611730020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T22:53:41Z","timestamp":1657407221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108932611730020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S108932611730020X"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2017.03.003","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Manifestations of Hepatitis C Virus","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}